FGC, E. P., RM, R., PFS, d. C., SCS, d. S., & ML, d. A. F. (2020). Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn's disease. BMC gastroenterology, 20(1), 35. https://doi.org/10.1186/s12876-020-1183-x
Chicago Style (17th ed.) CitationFGC, E Penna, Rosa RM, da Cunha PFS, de Souza SCS, and de Abreu Ferrari ML. "Faecal Calprotectin Is the Biomarker That Best Distinguishes Remission from Different Degrees of Endoscopic Activity in Crohn's Disease." BMC Gastroenterology 20, no. 1 (2020): 35. https://doi.org/10.1186/s12876-020-1183-x.
MLA (9th ed.) CitationFGC, E Penna, et al. "Faecal Calprotectin Is the Biomarker That Best Distinguishes Remission from Different Degrees of Endoscopic Activity in Crohn's Disease." BMC Gastroenterology, vol. 20, no. 1, 2020, p. 35, https://doi.org/10.1186/s12876-020-1183-x.